These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9870974)

  • 41. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX.
    Lees GJ; Leong W
    Neuroreport; 1994 Oct; 5(16):2153-6. PubMed ID: 7532455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.
    Bernert H; Turski L
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
    Judge ME; Sheardown MJ; Jacobsen P; Honoré T
    Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury.
    Gensel JC; Tovar CA; Bresnahan JC; Beattie MS
    PLoS One; 2012; 7(3):e33519. PubMed ID: 22428066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic alterations in the cellular composition of spinal cord white matter following contusion injury.
    Rosenberg LJ; Zai LJ; Wrathall JR
    Glia; 2005 Jan; 49(1):107-20. PubMed ID: 15390101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage.
    Dohare P; Zia MT; Ahmed E; Ahmed A; Yadala V; Schober AL; Ortega JA; Kayton R; Ungvari Z; Mongin AA; Ballabh P
    J Neurosci; 2016 Mar; 36(11):3363-77. PubMed ID: 26985043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The AMPA antagonist NBQX protects thalamic reticular neurons from degeneration following cardiac arrest in rats.
    Ross DT; Brasko J; Patrikios P
    Brain Res; 1995 Jun; 683(1):117-28. PubMed ID: 7552336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells.
    Balchen T; Diemer NH
    Neuroreport; 1992 Sep; 3(9):785-8. PubMed ID: 1384770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A; Durand J
    Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NBQX attenuates excitotoxic injury in developing white matter.
    Follett PL; Rosenberg PA; Volpe JJ; Jensen FE
    J Neurosci; 2000 Dec; 20(24):9235-41. PubMed ID: 11125001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels.
    Nilsson P; Laursen H; Hillered L; Hansen AJ
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):262-70. PubMed ID: 8594058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
    Richter A; Löscher W; Löschmann PA
    Eur J Pharmacol; 1993 Feb; 231(2):287-91. PubMed ID: 8384114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strychnine-sensitive modulation is selective for non-noxious somatosensory input in the spinal cord of the rat.
    Sherman SE; Loomis CW
    Pain; 1996 Aug; 66(2-3):321-30. PubMed ID: 8880856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathological changes in the white matter after spinal contusion injury in the rat.
    Ek CJ; Habgood MD; Dennis R; Dziegielewska KM; Mallard C; Wheaton B; Saunders NR
    PLoS One; 2012; 7(8):e43484. PubMed ID: 22952690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain.
    Zahn PK; Umali E; Brennan TJ
    Pain; 1998 Feb; 74(2-3):213-23. PubMed ID: 9520236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Turski L; Jacobsen P; Honoré T; Stephens DN
    J Pharmacol Exp Ther; 1992 Feb; 260(2):742-7. PubMed ID: 1371159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
    Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats.
    Gaviria M; Privat A; d'Arbigny P; Kamenka J; Haton H; Ohanna F
    Brain Res; 2000 Aug; 874(2):200-9. PubMed ID: 10960605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-N-methyl-D-aspartate (NMDA) receptor antagonist 1,2,3, 4-tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide (NBQX) decreases functional disorders in cytotoxic brain oedema.
    Häntzschel A; Andreas K
    Arch Toxicol; 2000 Jan; 73(10-11):581-7. PubMed ID: 10663390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.